Characterization of behavioral and endocrine effects of LSD on zebrafish

Behavioural Brain Research

Volumn 214, Issue 2, 2010, Pages 277-284

  Grossman, Leah ^a   Utterback, Eli ^a   Stewart, Adam ^a   Gaikwad, Siddharth ^a   Chung, Kyung Min ^a   Suciu, Christopher ^a   Wong, Keith ^a   Elegante, Marco ^a   Elkhayat, Salem ^a   Tan, Julia ^a   Gilder, Thomas ^a   Wu, Nadine ^a   DiLeo, John ^a   Cachat, Jonathan ^a   Kalueff, Allan V ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adult zebrafish; Behavioral paradigms; Cortisol; Hallucinogenic drugs; LSD; Screening

Indexed keywords

HYDROCORTISONE; LYSERGIDE; PSYCHEDELIC AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG ABUSE; ENDOCRINE FUNCTION; FEMALE; HORMONE DETERMINATION; LIGHT DARK CYCLE; MALE; MAZE TEST; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; VIDEORECORDING; ZEBRA FISH;

ANIMALS; BEHAVIOR, ANIMAL; BODY FLUIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALLUCINOGENS; HYDROCORTISONE; LYSERGIC ACID DIETHYLAMIDE; MALE; VIDEO RECORDING; ZEBRAFISH;

EID: 77955266291     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.05.039     Document Type: Article

References (82)

1. Pacifici R., Zuccaro P., Farre M., Pichini S., Di Carlo S., Roset P.N., et al. The pharmacology of lysergic acid diethylamide: a review. CNS Neurosci Ther 2008, 14(4):295-314.
2. Cohen S. Psychotomimetic agents. Annu Rev Pharmacol 1967, 7:301-318.
3. Siegel R.K. Hallucinogens and attentional dysfunction: a model for drug effects and reality testing. The psychopharmacology of hallucinogens 1978, Pergamon Press, Elmsford, NY, p. 268-296. R.C. Stillman, R.E. Willette (Eds.).
4. Nichols D.E. Hallucinogens. Pharmacol Ther 2004, 101(2):131-181.
5. Backstrom J.R., Chang M.S., Chu H., Niswender C.M., Sanders-Bush E. Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD). Neuropsychopharmacology 1999, 21(2 Suppl):77S-81S.
6. Gonzalez-Maeso J., Sealfon S.C. Psychedelics and schizophrenia. Trends Neurosci 2009, 32(4):225-232.
7. Grailhe R., Waeber C., Dulawa S.C., Hornung J.P., Zhuang X., Brunner D., et al. Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor. Neuron 1999, 22(3):581-591.
8. Gresch P.J., Strickland L.V., Sanders-Bush E. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors. Neuroscience 2002, 114(3):707-713.
9. Palenicek T., Hlinak Z., Bubenikova-Valesova V., Novak T., Horacek J Sex differences in the effects of N,N-diethyllysergamide (LSD) on behavioural activity and prepulse inhibition. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34(4):588-596.
10. Halberstadt AL, Geyer MA. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor. Psychopharmacology (Berl) 208(2):179-89.
11. Mittman S.M., Geyer M.A. Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens. Psychopharmacology (Berl) 1989, 98(3):321-329.
12. Reissig C.J., Eckler J.R., Rabin R.A., Winter J.C. The 5-HT1A receptor and the stimulus effects of LSD in the rat. Psychopharmacology (Berl) 2005, 182(2):197-204.
13. Gonzalez-Maeso J., Weisstaub N.C., Zhou M., Chan P., Ivic L., Ang R., et al. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 2007, 53(3):439-452.
14. Marona-Lewicka D., Nichols D.E. Complex stimulus properties of LSD: a drug discrimination study with alpha 2-adrenoceptor agonists and antagonists. Psychopharmacology (Berl) 1995, 120(4):384-391.
15. Jerome, d-Lysergic acid diethylamid investigator's brochure; 2008.
16. Seeman P., Guan H.C., Hirbec H. Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil. Synapse 2009, 63(8):698-704.
17. Marona-Lewicka D., Chemel B.R., Nichols D.E. Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI. Psychopharmacology (Berl) 2009, 203(2):265-277.
18. Marona-Lewicka D., Thisted R.A., Nichols D.E. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis. Psychopharmacology (Berl) 2005, 180(3):427-435.
19. Eveloff H.H. The LSD syndrome. A review. Calif Med 1968, 109(5):368-373.
20. Levy R.M. Diazepam for L.S.D. intoxication. Lancet 1971, 1(7712):1297.
21. Sigafoos J., Green V.A., Edrisinha C., Lancioni G.E. Flashback to the 1960s: LSD in the treatment of autism. Dev Neurorehabil 2007, 10(1):75-81.
22. Simmons J.Q., Leiken S.J., Lovaas O.I., Schaeffer B., Perloff B. Modification of autistic behavior with LSD-25. Am J Psychiatry 1966, 122(11):1201-1211.
23. Siegel RK. Studies of hallucinogens in fish, birds, mice and men: the behavior of " psychedelic" populations. Adv Neuropsychopharmacol. Proceedings of the Symposium on VII Congress; 1971. p. 311-18.
24. Krsiak M. Timid singly-housed mice: their value in prediction of psychotropic activity of drugs. Br J Pharmacol 1975, 55(1):141-150.
25. Geyer M.A., Light R.K. LSD-induced alterations of investigatory responding in rats. Psychopharmacology (Berl) 1979, 65(1):41-47.
26. Uyeno E.T., Benson W.M. Effects of lysergic acid diethylamide on attack behavior of male albino mice. Psychopharmacologia 1965, 7(1):20-26.
27. Silverman A.P. Barbiturates, lysergic acid diethylamide, and the social behaviour of laboratory rats. Psychopharmacologia 1966, 10(2):155-171.
28. Krebs-Thomson K., Paulus M.P., Geyer M.A. Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors. Neuropsychopharmacology 1998, 18(5):339-351.
29. Mittman S.M., Geyer M.A. Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol. Psychopharmacology (Berl) 1991, 105(1):69-76.
30. Castellano C. Effects of LSD-25 on avoidance behavior and locomotor activity in mice. Psychopharmacology (Berl) 1979, 62(2):145-149.
31. Krsiak M. Effects of drugs on behaviour of aggressive mice. Br J Pharmacol 1979, 65(3):525-533.
32. Frederick D.L., Gillam M.P., Lensing S., Paule M.G. Acute effects of LSD on rhesus monkey operant test battery performance. Pharmacol Biochem Behav 1997, 57(4):633-641.
33. Chaplygina S.R. The effect of lysergic acid diethylamide on memory in mice. Zh Vyssh Nerv Deiat Im I P Pavlova 1975, 25(1):66-69.
34. Adams L.M., Geyer M.A. A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats. Behav Neurosci 1985, 99(5):881-900.
35. Adams L.M., Geyer M.A. LSD-induced alterations of locomotor patterns and exploration in rats. Psychopharmacology (Berl) 1982, 77(2):179-185.
36. Gupta An examination of the effect of central nervous system stimulant and anti-depressant drugs on open field performance in rats. Eur J Pharmacol 1971, 13:341-346.
37. Krebs-Thomson K., Geyer M.A. The role of 5-HT(1A) receptors in the locomotor-suppressant effects of LSD: WAY-100635 studies of 8-OH-DPAT, and LSD in rats. Behav Pharmacol 1996, 7(6):551-559.
38. Geyer M.A., Light R.K., Rose G.J., Petersen L.R., Horwitt D.D., Adams L.M., et al. A characteristic effect of hallucinogens on investigatory responding in rats. Psychopharmacology (Berl) 1979, 65(1):35-40.
39. Abramson H.A., Evans L.T. Lysergic Acid Diethylamide (Lsd-25). 34. Comparison with Effect of Psilocybin on the Siamese Fighting Fish. J Psychol 1963, 56:363-374.
40. Gettner H.H., Rolo A., Abramson H.A. Lysergic acid diethylamide (Lsd-25). Xxxv. Comparison of effect on siamese fighting fish and goldfish. J Psychol 1964, 58:57-63.
41. Abramson H.A., Gettner H.H., Carone P.A., Rolo A., Krinsky L. The intracranial injection of drug in goldfish. I: Hallucinogens and their antagonism to smooth muscle activity. J Asthma Res 1979, 16(2):55-61.
42. Trout D.L. Interaction of serotonin and lysergic acid diethylamide in the Siamese fighting fish. J Pharmacol Exp Ther 1957, 121(1):130-135.
43. Arbit J. Effects of LSD-25 upon Betta splendens: reliability of a bioassay technique. J Appl Physiol 1957, 10(2):317-318.
44. Abramson H.A., Gettner H.H., Hewitt M.P., Dean G. Effect of lysergic acid diethylamide on the surfacing behaviour of large carp. Nature 1962, 193:320-321.
45. Chessick R.D., Kronholm J., Maier G. Effect of lysergic acid diethylamide (Lsd-25)and other drugs on tropical fish. J Nerv Ment Dis 1963, 137:389-394.
46. Chessick R.D., Kronholm J., Beck M., Maier G. Effect of pretreatment with tryptamine, tryptophan and dopa on Lsd reaction in tropical fish. Psychopharmacologia 1964, 5:390-392.
47. Abramson H.A., Evans L.T. Lysergic acid diethylamide (LSD 25). II. Psychobiological effects on the Siamese fighting fish. Science 1954, 120(3128):990-991.
48. Dyck E. Flashback: psychiatric experimentation with LSD in historical perspective. Can J Psychiatry 2005, 50(7):381-388.
49. Geyer M.A. Why study hallucinogenic drugs in animals?. Heffer Rev Psychedel Res 1998, 1:33-38.
50. Sessa B. Is it time to revisit the role of psychedelic drugs in enhancing human creativity?. J Psychopharmacol 2008, 22(8):821-827.
51. Maximino C, de Brito TM, Dias CA, Gouveia A Jr., Morato S. Scototaxis as anxiety-like behavior in fish. Nat Protoc 5(2):209-16.
52. Cachat J., Canavello P., Elegante M., Bartels B., Hart P., Bergner C., et al. Modeling withdrawal syndrome in zebrafish. Behav Brain Res 2010, 208(2):371-376.
53. Egan R.J., Bergner C.L., Hart P.C., Cachat J.M., Canavello P.R., Elegante M.F., et al. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res 2009, 205(1):38-44.
54. Stewart A., Kadri F., DiLeo J., Chung K., Cachat J., Goodspeed J., et al. The developing utility of zebrafish in modeling neurobehavioral disorders. Int J Comp Psychol 2010, 23:104-121.
55. Wong K., Elegante M., Bartels B., Elkhayat S., Tien D., Roy S., Goodspeed J., et al. Analyzing habituation responses to novelty in zebrafish (Danio rerio). Behav Brain Res 2010, 208(2):450-457.
56. Kaslin J., Panula P. Comparative anatomy of the histaminergic and other aminergic systems in zebrafish (Danio rerio). J Comp Neurol 2001, 440(4):342-377.
57. Gabriel J.P., Mahmood R., Kyriakatos A., Soll I., Hauptmann G., Calabrese R.L., et al. Serotonergic modulation of locomotion in zebrafish: endogenous release and synaptic mechanisms. J Neurosci 2009, 29(33):10387-10395.
58. Braida D., Limonta V., Pegorini S., Zani A., Guerini-Rocco C., Gori E., et al. Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement. Psychopharmacology (Berl) 2007, 190(4):441-448.
59. Westerfield M. The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio). 5th ed. Eugene: University of Oregon Press; 2007.
60. Levin E.D., Bencan Z., Cerutti D.T. Anxiolytic effects of nicotine in zebrafish. Physiol Behav 2007, 90(1):54-58.
61. Bencan Z., Sledge D., Levin E.D. Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety. Pharmacol Biochem Behav 2009, 94(1):75-80.
62. Denmark A., Tien D., Wong K., Chung A., Cachat J., Goodspeed J., et al. The effects of chronic social defeat stress on mouse self-grooming behavior and its patterning. Behav Brain Res 2010, 208(2):553-559.
63. Kalueff A.V., Ren-Patterson R.F., LaPorte J.L., Murphy D.L. Domain interplay concept in animal models of neuropsychiatric disorders: a new strategy for high-throughput neurophenotyping research. Behav Brain Res 2008, 188(2):243-249.
64. Serra E.L., Medalha C.C., Mattioli R. Natural preference of zebrafish (Danio rerio) for a dark environment. Braz J Med Biol Res 1999, 32(12):1551-1553.
65. Choleris E., Thomas A.W., Kavaliers M., Prato F.S. A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci Biobehav Rev 2001, 25(3):235-260.
66. Crawley J.N. Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol 2007, 17(4):448-459.
67. Crawley J.N. Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment Retard Dev Disabil Res Rev 2004, 10(4):248-258.
68. Siegel RK. Intoxication: the universal drive for mind-altering substances. Lake Book Inc.; 2005. p. 372.
69. Echevarria D.J., Hammack C.M., Pratt D.W., Hosemann J.D. A novel behavioral test battery to assess global drug effects using the zebrafish. Int J Comp Psychol 2008, 21(1):19-34.
70. Gerlai R., Lee V., Blaser R. Effects of acute and chronic ethanol exposure on the behavior of adult zebrafish (Danio rerio). Pharmacol Biochem Behav 2006, 85(4):752-761.
71. Trompouki E., Zon LI Small molecule screen in zebrafish and HSC expansion. Methods Mol Biol 2010, 636:301-316.
72. Arslanova D., Yang T., Xu X., Wong S.T., Augelli-Szafran C.E., Xia W. Phenotypic analysis of images of zebrafish treated with Alzheimer's gamma-secretase inhibitors. BMC Biotechnol 2010, 10(1):24.
73. Hortopan G.A., Dinday M.T., Baraban SC Zebrafish as a model for studying genetic aspects of epilepsy. Dis Model Mech 2010, 3(3-4):144-148.
74. Weiss B., Abramson H.A., Baron M.O. Lysergic acid diethylamide (LSD-25). XXV. Effect of potassium cyanide and other oxidase and respiratory inhibitors on the Siamese fighting fish. AMA Arch Neurol Psychiatry 1958, 80(3):345-350.
75. Miller N., Gerlai R. Quantification of shoaling behaviour in zebrafish (Danio rerio). Behav Brain Res 2007, 184(2):157-166.
76. Larson E.T., O'Malley D.M., Melloni R.H. Aggression and vasotocin are associated with dominant-subordinate relationships in zebrafish. Behav Brain Res 2006, 167(1):94-102.
77. Paull G.C., Filby A.L., Giddins H.G., Coe T.S., Hamilton P.B., Tyler C.R. Dominance hierarchies in zebrafish (Danio rerio) and their relationship with reproductive success. Zebrafish 2010, 7(1):109-117.
78. Wright D., Rimmer L.B., Pritchard V.L., Krause J., Butlin R.K. Inter and intra-population variation in shoaling and boldness in the zebrafish (Danio rerio). Naturwissenschaften 2003, 90(8):374-377.
79. Bliss E.L., Migeon C.J., Branch C.H., Samuels L.T. Reaction of the adrenal cortex to emotional stress. Psychosom Med 1956, 18(1):56-76.
80. Sackler A.M., Weltman A.S., Owens H. Effects of lysergic acid diethylamide on urinary 17-ketosteroid and 17-OH corticosteroid levels of female rats. Nature 1963, 198:1119-1120.
81. Weltman A.S., Sackler A.M. Metabolic and endocrine effects of lysergic acid diethylamide (LSD-25) on male rats. J Endocrinol 1966, 34(1):81-90.
82. Winberg S., Nilsson A., Hylland P., Soderstom V., Nilsson G.E. Serotonin as a regulator of hypothalamic-pituitary-interrenal activity in teleost fish. Neurosci Lett 1997, 230(2):113-116.